Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
ERG (Evolution Research Group) is a U.S.-based clinical research site company. Its official website positions it as providing clinical trial execution support for sponsors and CROs. It is not a typical SaaS or enterprise software product; instead, it offers services for Phase I-IV inpatient and outpatient studies through its owned and affiliated clinical research sites, expert teams, patient database, and centralized operating system.
Based on the site content, ERG focuses on 50+ indications, including CNS, psychiatry, neurology, pain, healthy volunteers, diabetes, NASH, and renal/hepatic impairment. Its network has 400+ beds and mentions a 130+ bed Phase I facility in Miami, dedicated acute pain research facilities, postoperative analgesia facilities, as well as capabilities such as pharmacy, infusion/formulation, PSG, qEEG/EEG, FibroScan, and CSF sampling. For patient recruitment, ERG has a database of 215,000+ patients and says it can reach 32 million potential patients, supported by centralized recruitment, marketing teams, community outreach, and referral relationships.
The official website does not disclose packages, subscriptions, or pricing. Its services are closer to project-based clinical research partnerships, with customized quotes based on study phase, indication, sites, beds, recruitment, data management, and regulatory requirements. After Lotus Clinical Research joined ERG, the company expanded its full-service CRO capabilities, including regulatory strategy, project management, biostatistics, data management, and monitoring.
Its strengths are deep specialty site resources, strong experience in CNS and pain research, well-developed early-phase clinical facilities, and reduced execution variability across multiple sites through centralized operations. Its large patient database and community outreach are also helpful for recruitment. The limitations are that, as a non-SaaS product, the website does not disclose key enterprise software metrics such as APIs, permissions, cloud deployment, software integrations, or security certifications; pricing, service SLAs, and specific contract models are also not transparent.
Suitable for pharmaceutical companies, biotech companies, and CROs looking for U.S. clinical trial sites, early-phase research, CNS/pain expertise, patient recruitment, or expanded CRO services. Not suitable for teams simply looking for clinical trial management SaaS, EDC/ePRO software, or a developer API platform.
The content does not provide information on access from China, Chinese-language services, or local compliance in China. Website accessibility cannot be determined and is marked as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on ergclinical.com official site.
ergclinical.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach ergclinical.com directly.